This article was written by Follow Alberto holds a Master’s degree in Business Economics. During his academic career he acquired an extensive managerial and...
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
Some people may refer to their company’s headquarters as the Mother Ship. But economist Robert Shiller has a different theory about the relationship between...
Introduction In May, I wrote an article titled Phillips 66: Harvesting Juicy Energy Dividends. Since then, the stock has risen by 23%, almost hitting...
Cashless to Bankless: How Is Money Changing? Speculation about the move towards a cashless economy increased considerably at the beginning of the decade. As...
Introduction iTeos Therapeutics (NASDAQ:ITOS), a clinical-stage biopharmaceutical company, focuses on advancing immuno-oncology treatments for cancer patients. Building on their expertise in tumor immunology and...
The Federal Bureau of Prisons (BOP) transferred tens of thousands of prisoners from institutions to home confinement under the CARES Act, which removed health-vulnerable...
Introduction As a dividend growth investor, I focus on discovering new chances for investments in assets that generate income. Whenever I come across appealing...
Chances are you already have exposure to Nvidia Corp. NVDA, -2.60% in your investment portfolio. Just about any actively managed large-cap U.S. fund with...